Lubach J - Search Results

1

Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing.

Moon C, Sahakijpijarn S, Maier EY, Taft DR, Jara MO, Praphawatvet T, Manandhar R, Shetty N, Lubach J, Narang A, Nagapudi K, Williams RO 3rd. Moon C, et al. Among authors: lubach j. Mol Pharm. 2024 Feb 5;21(2):564-580. doi: 10.1021/acs.molpharmaceut.3c00719. Epub 2024 Jan 12. Mol Pharm. 2024. PMID: 38215042

2

Investigation of the rat model for preclinical evaluation of pH-dependent oral absorption in humans.

Lubach JW, Chen JZ, Hau J, Imperio J, Coraggio M, Liu L, Wong H. Lubach JW, et al. Mol Pharm. 2013 Nov 4;10(11):3997-4004. doi: 10.1021/mp400283j. Epub 2013 Aug 20. Mol Pharm. 2013. PMID: 23961831

3

Solid-State Characterization of Novel Propylene Glycol Ester Solvates Isolated from Lipid Formulations.

Chakravarty P, Kothari S, Deese A, Lubach JW. Chakravarty P, et al. Mol Pharm. 2015 Jul 6;12(7):2551-7. doi: 10.1021/mp5007695. Epub 2015 Jun 3. Mol Pharm. 2015. PMID: 26013841

4

A rational approach towards development of amorphous solid dispersions: Experimental and computational techniques.

Chakravarty P, Lubach JW, Hau J, Nagapudi K. Chakravarty P, et al. Among authors: lubach jw. Int J Pharm. 2017 Mar 15;519(1-2):44-57. doi: 10.1016/j.ijpharm.2017.01.003. Epub 2017 Jan 4. Int J Pharm. 2017. PMID: 28063904

5

In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion.

Haser A, Cao T, Lubach JW, Zhang F. Haser A, et al. Mol Pharm. 2018 Mar 5;15(3):1226-1237. doi: 10.1021/acs.molpharmaceut.7b01057. Epub 2018 Feb 19. Mol Pharm. 2018. PMID: 29412681

6

Understanding Phase Behavior of Nearly Energetically Equivalent Polymorphs To Achieve Controlled Crystallization for a Nav1.7 Pain Inhibitor Compound.

Chakravarty P, DiPasquale AG, Stumpf A, Lubach JW, Nagapudi K. Chakravarty P, et al. Mol Pharm. 2018 Nov 5;15(11):5072-5080. doi: 10.1021/acs.molpharmaceut.8b00658. Epub 2018 Sep 28. Mol Pharm. 2018. PMID: 30216726

7

Impact of Method of Preparation of Amorphous Solid Dispersions on Mechanical Properties: Comparison of Coprecipitation and Spray Drying.

Hou HH, Rajesh A, Pandya KM, Lubach JW, Muliadi A, Yost E, Jia W, Nagapudi K. Hou HH, et al. J Pharm Sci. 2019 Feb;108(2):870-879. doi: 10.1016/j.xphs.2018.09.008. Epub 2018 Sep 19. J Pharm Sci. 2019. PMID: 30244013

8

Rapid Characterization of Formulated Pharmaceuticals Using Fast MAS ¹H Solid-State NMR Spectroscopy.

Hirsh DA, Wijesekara AV, Carnahan SL, Hung I, Lubach JW, Nagapudi K, Rossini AJ. Hirsh DA, et al. Among authors: lubach jw. Mol Pharm. 2019 Jul 1;16(7):3121-3132. doi: 10.1021/acs.molpharmaceut.9b00343. Epub 2019 Jun 4. Mol Pharm. 2019. PMID: 31095913

9

Effect of Counterions on Dissolution of Amorphous Solid Dispersions Studied by Surface Area Normalized Dissolution.

Chen Y, Lubach JW, Tang S, Narang AS. Chen Y, et al. Mol Pharm. 2021 Sep 6;18(9):3429-3438. doi: 10.1021/acs.molpharmaceut.1c00325. Epub 2021 Aug 2. Mol Pharm. 2021. PMID: 34338529

10

Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies.

Chiang CW, Lubach JW, Chen T, Chin S, Ly J, Zhang W, Hou HH, Nagapudi K. Chiang CW, et al. Among authors: lubach jw. Mol Pharm. 2023 May 1;20(5):2452-2464. doi: 10.1021/acs.molpharmaceut.2c01056. Epub 2023 Apr 3. Mol Pharm. 2023. PMID: 37010134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters